Avenir Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.98 M
as on 10-12-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 10-12-2024
- Revenue 125.65%
(FY 2022)
- Profit 107.79%
(FY 2022)
- Ebitda 401.29%
(FY 2022)
- Net Worth 3.51%
(FY 2022)
- Total Assets 21.44%
(FY 2022)
About Avenir Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.98 M.
The company currently has active open charges totaling ₹4.00 M.
Rajneesh Goel, Seema Goel, and Shubham Goel serve as directors at the Company.
- CIN/LLPIN
U24232UR2005PTC030650
- Company No.
030650
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- LocationUttranchal, Uttarakhand
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Avenir Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Goel  | Director | 21-Sep-2018 | Current |
| Rajneesh Goel | Director | 19-Sep-2005 | Current |
| Seema Goel | Director | 19-Sep-2005 | Current |
Financial Performance of Avenir Life Science.
Avenir Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 125.65% increase. The company also saw a substantial improvement in profitability, with a 107.79% increase in profit. The company's net worth moved up by a moderate rise of 3.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avenir Life Science?
Unlock access to Avenir Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Technica Labs & Pharma Private LimitedActive 26 years 9 monthsRajneesh Goel and Seema Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Oct 2023 | ₹4.00 M | Open |
How Many Employees Work at Avenir Life Science?
Unlock and access historical data on people associated with Avenir Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avenir Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avenir Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
